Kassandra Lepack

Title: Kassandra Lepack: Innovator in Hepatitis C Research

Introduction

Kassandra Lepack is a prominent inventor based in Calgary, Canada, known for her significant contributions to the field of pharmaceutical research. With a total of four patents to her name, she has made remarkable strides in developing treatments for hepatitis C viral infections.

Latest Patents

Kassandra's latest patents focus on hepatitis C virus inhibitors. The inventions provide compounds of formula (I), wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of replication of the hepatitis C virus. These inventions also include pharmaceutical compositions comprising such compounds, methods of using them to treat hepatitis C viral infections, and processes and intermediates useful for preparing these compounds.

Career Highlights

Kassandra works at Theravance Biopharma R&D IP, LLC, where she continues to advance her research in antiviral therapies. Her work has been instrumental in the development of innovative solutions for combating hepatitis C, a virus that affects millions worldwide.

Collaborations

Kassandra has collaborated with notable colleagues, including Robert Murray McKinnell and Daniel D Long, to further enhance her research efforts and contribute to the scientific community.

Conclusion

Kassandra Lepack's dedication to innovation in hepatitis C research exemplifies her commitment to improving public health through her inventions. Her work continues to pave the way for new treatments and therapies in the fight against viral infections.